Venetoclax dose-escalation and obinutuzumab treatment schedule in a clinical trial

Deborah Sims is a young chronic lymphocytic leukaemia (CLL) patient, undertaking a clinical trial of obinutuzumab and venetoclax (ABT-199). Here, Deborah describes the dose-escalation regime of venetoclax and how it fits with the obinutuzumab treatment schedule. At this point, Deborah has done the first round of obinutuzumab.
To learn more about Deborah's story visit her blog at abtandme.com

Visit our website | http://www.patientpower.eu/
Follow on Twitter | https://twitter.com/patientpowereu
Like on Facebook | https://www.fb.com/patientpower.europe

Видео Venetoclax dose-escalation and obinutuzumab treatment schedule in a clinical trial канала Patient Power Europe